New York State Common Retirement Fund
MPLT

New York State Common Retirement Fund’s MapLight Therapeutics MPLT Stock Holding History

New York State Common Retirement Fund’s Portfolio MPLT Stock Details MPLT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$190K Hold
5,300
– – ﹤0.01% 2392
2026
Q1 		$108K Hold
5,300
– – ﹤0.01% 2490
2025
Q4 		$93.1K Buy
+5,300
New +$88.8K ﹤0.01% 2636

Other funds holding MPLT

NHAS
Novo Holdings A/S Hellerup, Denmark $1.72B AUM 106.92% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $750M AUM 127.27% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NFGH
Nan Fung Group Holdings Kai Tak, Hong Kong $131M AUM 86.64% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $288M AUM 313.93% 1-Year Est. Return
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

New York State Common Retirement Fund's MPLT Position: Q2 2026 in Review

New York State Common Retirement Fund held its MapLight Therapeutics (MPLT) position steady in Q2 2026 at 5,300 shares worth $190K. The position accounts for ﹤0.01% of the portfolio, ranked #2392.

New York State Common Retirement Fund first reported a position in MPLT in Q4 2025 and has held it in 3 quarters since. 105 funds tracked by Wall St. Rank hold MPLT as of Q2 2026.

  • New York State Common Retirement Fund held 5,300 shares of MapLight Therapeutics worth $190K as of Q2 2026.
  • New York State Common Retirement Fund left its MapLight Therapeutics share count unchanged in Q2 2026.
  • MapLight Therapeutics made up ﹤0.01% of New York State Common Retirement Fund's portfolio in Q2 2026, its #2392 holding.
  • New York State Common Retirement Fund first reported a position in MapLight Therapeutics in Q4 2025 and has held it in 3 quarters since.
  • 105 funds tracked by Wall St. Rank held MapLight Therapeutics as of Q2 2026.

Based on New York State Common Retirement Fund's 13F filing for Q2 2026, filed 29 Jul 2026.